Is High Sensibility Troponins a Dialysable Marker in Hemodialysis Patients and Does it Have Prognostic Value? (TnT-HD)

Université de Sherbrooke

Status: Completed

Conditions: Renal Failure

Treatments: Other: Hs-TNT dosage

Study type: Interventional

Funder types: Other

Identifiers

NCT02111733

TnT-HD

Details and patient eligibility

About

Evaluation of High sensibility troponin levels modification by hemodialysis in terminal renal failure patient at Sherbrooke University Hospital Center as determined by serial measurements. Verification of potential effects of these levels and their variation as predictors of cardiovascular outcomes and events at 6 and 12 months.

Full description

Recruiting of hemodialysis patients of the nephrology renal supplementation clinics at Sherbrooke University Hospital Center to measure three blood level of high-sensibility troponins before and after standard dialysis. Verification on the variation of these levels after dialysis. Follow-up at 6 and 12 months of the patient for Cardiovascular events and death and verification of a possible predictive value of troponin blood levels for these events.

Enrollment: 43 patients

Sex: All

Ages: 50+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• over 50 years, no symptoms, over 1 months of hemodialysis

Exclusion criteria

• 1 or more in the last month; Acute coronary syndrome, Heart failure decompensated, Myo or Pericarditis, Pulmonary embolism, Sepsis/shock, Stroke or transient ischemic attack, Malignant high blood pressure, Arrythmia, electrical cardio-version, major trauma, significant burnings (>25%), Chemotherapy, Cardiovascular surgery, percutaneous angio-intervention,
• Chronic systemic disease (sarcoidosis, amyloidosis, LED, Etc.)

Trial design

43 participants in 1 patient group

Hs-TnT

Experimental group

Description:

Hs-TNT dosage

Treatment:

Other: Hs-TNT dosage